IL6ST and depressive symptom measurement: The behavioral results indicated that sgp130 significantly alleviated the anxiety‐ and depression‐like behaviors (Figure S6B–D, Supporting Information) and improved the atrophy of astrocytes induced by CSDS (Figure S6E, Supporting Information).